MindMaze Therapeutics Holding (CHIX:MMTXZ) Interest Expense: CHF Mil (TTM As of Dec. 2025)


CHIX:MMTXZ MindMaze Therapeutics Holding SA CHIX:MMTXZ
15 GF Score
Price CHF0.21
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding Interest Expense?

MindMaze Therapeutics Holding CHIX:MMTXZ +4.74% 15 Interest Expense is CHF Mil as of Dec. 2025. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. MindMaze Therapeutics Holding's interest expense for the six months ended in Dec. 2025 was CHF -0.27 Mil. MindMaze Therapeutics Holding does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. MindMaze Therapeutics Holding's Operating Income for the six months ended in Dec. 2025 was CHF -10.52 Mil. MindMaze Therapeutics Holding's Interest Expense for the six months ended in Dec. 2025 was CHF -0.27 Mil. MindMaze Therapeutics Holding did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MindMaze Therapeutics Holding  (CHIX:MMTXz) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MindMaze Therapeutics Holding's Interest Expense for the six months ended in Dec. 2025 was CHF-0.27 Mil. Its Operating Income for the six months ended in Dec. 2025 was CHF-10.52 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was CHF1.18 Mil.

MindMaze Therapeutics Holding's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

MindMaze Therapeutics Holding did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

MindMaze Therapeutics Holding Interest Expense Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding Interest Expense Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
Interest Expense
0.00 -0.27

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
Interest Expense 0.00 -0.27
CHIX:MMTXZ
15GF Score
MindMaze Therapeutics Holding SA CHIX:MMTXZ
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of CHF Mil mean?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Interest Expense of CHF Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on MindMaze Therapeutics Holding and its competitors.
Is MindMaze Therapeutics Holding's Interest Expense too high?
MindMaze Therapeutics Holding's current Interest Expense is CHF Mil. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Interest Expense compare to VRTX and REGN?
MindMaze Therapeutics Holding's Interest Expense of CHF Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on MindMaze Therapeutics Holding and its competitors. MindMaze Therapeutics Holding's current Interest Expense is CHF Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Interest Expense of CHF Mil. The current Interest Expense is CHF Mil. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Interest Expense is CHF Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges RLFTY:USAMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score

Get the complete analysis for CHIX:MMTXZ

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.21
Price